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Bartha M KnoppersAbstract
Policymaking is both an art and a science. It is a long process of research, debate and consensus (where possible).
The elaboration of the Framework for Responsible Sharing of Genomic and Health-Related Data serves as an illustration
of this process.
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Introduction: the many aims of ethics policymaking
Scientists have labs and algorithms, but those of us in
the “ELSI” (Ethical, Legal and Social Issues) community
have only words. Somehow this translates into a common
assumption in the biomedical research and funding com-
munities that policies, procedures, consent forms and
the like seem to grow on trees, or at least germinate in
our dreams and magically appear at will or when
needed. Yet, one would be mistaken in this assumption.
Ethics policymaking in the biomedical research sector
is quite often as delicate, incremental and grounded in
precedent as scientific research conducted in a lab.
The aims of ethics policymaking in the biomedical
research sector are many: avoid being legalistic; be
context-specific; speak plainly; address the diversity of
issues, disciplines and cultures involved; facilitate harmon-
ization, compliance and oversight; include all relevant
stakeholders; be aspirational; be practical and yet, at the
same time, be principled. To that end, there is no doubt of
the need for foundational principles – that is, having a
common vision – before discussing the possibility of
detailed content. One has but to examine the principles
invoked by the HUGO Ethics Committee [1] in its first
decade of work to see their influence in prospectively
addressing emerging issues.A case study: the framework for responsible sharing of
genomic and health-related data
The development of the Framework for Responsible
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of the Global Alliance for Genomics and Health (GA4GH)
to “accelerate progress in human health by helping to
establish a common framework of harmonized approaches
to enable effective and responsible sharing of genomic and
clinical data …” [3], the elaboration of this Framework
epitomizes the laborious process of international ethics
policymaking.
A unique feature of the Framework, which has been
developed by the Regulatory and Ethics Working Group
of the GA4GH and its diverse partners (P3G-IPAC [4];
IRDiRC [5]; BioSHaRE [6]; H3Africa [7] and ISBER [8],
among others), is its reliance on human rights, especially
the UN’s Universal Declaration of Human Rights [9], for
guidance and inspiration. Human rights, precisely because
they are universal, are more robust and “actionable”
than traditional bioethics principles, which necessarily
complement these rights [10]. This Framework is guided
by the human rights of privacy, non-discrimination and
procedural fairness. But most importantly, the Framework
has as its foundations: the right of all citizens to benefit
from scientific progress; and its applications; the right to
scientific freedom; and, the rights of data producers and
users to be recognized for their contributions to research,
balanced by the rights of those who donate their data.
The human rights approach is not just a political move,
but a strategy that causes the biomedical research and
medical community to re-think and re-vitalize the debate
surrounding genomic and clinical data sharing. Human
rights in the domain of scientific research have largely
lain dormant since their first appearance in the United
Nations’ 1948 Universal Declaration of Human Rights.
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and Cultural Rights (a legally binding covenant signed
and ratified by 162 countries), they have been seemingly
forgotten by the international bioethics and legal com-
munities. The Framework hopes therefore, to finally
make these rights “actionable”. But how exactly was this
Framework built?
Lessons learned
The most essential ingredient for what was (and is, with
all policymaking) inevitably a long and arduous process
of discussion, drafting and re-drafting is the involvement
of people working closely together. Even more important
than the expertise and experience of individuals is their
goodwill and capacity for consensus. In short, egos have
no place in this environment of mutual trust and respect.
Openness to criticism, comments and discussion of every-
one’s favorite “wish list” of definitions, clauses, and so on
is the ultimate test of policymaking mettle. Moreover,
validation of the content of any policy developed through
broad exposure and input strengthens eventual buy-in
and use by the scientific community. A year in the
making, the Framework underwent ten versions following
meetings, postings on the Alliance website and public
presentations.
While drafting policy is not quantitative, qualitative,
empirical or systematic, it does nevertheless require
judgement and an in-depth understanding of past and
current approaches and controversies. Precedent mat-
ters. It seeks to reconcile universals and particulars, the
possible and the hoped-for, as well as acquire legitimacy
through use and usefulness over time. With respect to
the Framework, this meant understanding the issues of
data sharing as well as a “rigorous reining in” of unreal-
istic expectations. Moreover, those involved in either
drafting the Framework or commenting thereon had to
be seasoned international ELSI experts in touch with
and grounded in the worlds and reality of patients and
research participants, labs, biobanks, funders, and, legal
or ethical constraints across cultures. This is a dynamic
science at work. Cynicism could and should not hold
sway in this drafting mission in spite of the constant
need for a reality check.
Policymaking also requires patience. One should not
expect any immediate tangible impact. Real-world appli-
cation and citation of what are often self-regulatory
approaches occur over the long term. A self-regulatory
approach takes time to enter into the scientific culture
since it lacks the imprimatur and legitimacy of policies
emanating from recognized international bodies such as
UNESCO or WHO. But the impact is eventually felt. It
is heartening, for example, to witness the long term
impact of the 1996 Bermuda Principles that were drafted
by the genomics research community [11]. The self-regulatory approach can in fact be advantageous: the
development of the Framework directly involved the
persons it aims to guide, namely scientists, policymakers,
research participants, and patients. Thus, the language
and content speak to the reality it hopes to serve and
guide. However, cynics could see it as self-serving and
possibly akin to a conflict of interest. But whether damned
for its absence or criticized for its presence, the Frame-
work will hopefully fructify these nascent human rights by
their very interpretation in the context of global data
sharing.
Conclusion
To summarize then, no, policy does not grow on trees or
in ELSI scholars’ fanciful imaginations, but, to be viable, it
needs courage, nurturing and rigor…for there is always
the possibility of turbulent weather along the way!
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